KR102364978B1 - Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity - Google Patents
Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity Download PDFInfo
- Publication number
- KR102364978B1 KR102364978B1 KR1020210048079A KR20210048079A KR102364978B1 KR 102364978 B1 KR102364978 B1 KR 102364978B1 KR 1020210048079 A KR1020210048079 A KR 1020210048079A KR 20210048079 A KR20210048079 A KR 20210048079A KR 102364978 B1 KR102364978 B1 KR 102364978B1
- Authority
- KR
- South Korea
- Prior art keywords
- gold
- acid
- silver coins
- silver
- coins
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 238000012545 processing Methods 0.000 title claims abstract description 9
- 244000167230 Lonicera japonica Species 0.000 title claims abstract description 8
- 235000017617 Lonicera japonica Nutrition 0.000 title claims abstract description 7
- 230000003078 antioxidant effect Effects 0.000 title claims description 34
- 239000003963 antioxidant agent Substances 0.000 title description 24
- 235000006708 antioxidants Nutrition 0.000 title description 22
- 230000003579 anti-obesity Effects 0.000 title description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 85
- 229910052737 gold Inorganic materials 0.000 claims abstract description 85
- 239000010931 gold Substances 0.000 claims abstract description 85
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 83
- 229910052709 silver Inorganic materials 0.000 claims abstract description 83
- 239000004332 silver Substances 0.000 claims abstract description 83
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 31
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 23
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 22
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 21
- 235000013305 food Nutrition 0.000 claims description 21
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 claims description 18
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 18
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 18
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 18
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 18
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 18
- 229940074393 chlorogenic acid Drugs 0.000 claims description 18
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 18
- KRZBCHWVBQOTNZ-PSEXTPKNSA-N 3,5-di-O-caffeoyl quinic acid Chemical compound O([C@@H]1C[C@](O)(C[C@H]([C@@H]1O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 KRZBCHWVBQOTNZ-PSEXTPKNSA-N 0.000 claims description 17
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 claims description 17
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 claims description 17
- UFCLZKMFXSILNL-PSEXTPKNSA-N Isochlorogenic acid b Chemical compound O([C@@H]1C[C@@](O)(C[C@H]([C@H]1OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)O)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 UFCLZKMFXSILNL-PSEXTPKNSA-N 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 235000004883 caffeic acid Nutrition 0.000 claims description 14
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 13
- 229940074360 caffeic acid Drugs 0.000 claims description 13
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 13
- 230000001965 increasing effect Effects 0.000 claims description 13
- MVCIFQBXXSMTQD-UHFFFAOYSA-N 3,5-dicaffeoylquinic acid Natural products Cc1ccc(C=CC(=O)OC2CC(O)(CC(OC(=O)C=Cc3ccc(O)c(O)c3)C2O)C(=O)O)cc1C MVCIFQBXXSMTQD-UHFFFAOYSA-N 0.000 claims description 12
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims description 12
- UFCLZKMFXSILNL-BBLPPJRLSA-N (-) 4,5-dicaffeoylquinic acid Natural products OC=1C=C(C=CC=1O)C=CC(=O)O[C@@H]1C[C@@](C[C@H]([C@H]1OC(C=CC1=CC(=C(C=C1)O)O)=O)O)(C(=O)O)O UFCLZKMFXSILNL-BBLPPJRLSA-N 0.000 claims description 11
- UFCLZKMFXSILNL-BKUKFAEQSA-N 3,4-di-O-caffeoylquinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O UFCLZKMFXSILNL-BKUKFAEQSA-N 0.000 claims description 11
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 11
- UFCLZKMFXSILNL-UHFFFAOYSA-N NSC 649410 Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC1C(O)CC(O)(C(O)=O)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 UFCLZKMFXSILNL-UHFFFAOYSA-N 0.000 claims description 11
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 11
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 11
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 11
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 claims description 11
- 235000009498 luteolin Nutrition 0.000 claims description 11
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 claims description 11
- 235000005875 quercetin Nutrition 0.000 claims description 11
- 229960001285 quercetin Drugs 0.000 claims description 11
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 11
- 235000005493 rutin Nutrition 0.000 claims description 11
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 11
- 229960004555 rutoside Drugs 0.000 claims description 11
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 claims description 9
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000003672 processing method Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 229950009125 cynarine Drugs 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 229930003935 flavonoid Natural products 0.000 description 19
- 150000002215 flavonoids Chemical class 0.000 description 19
- 235000017173 flavonoids Nutrition 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 150000007965 phenolic acids Chemical class 0.000 description 18
- 230000002292 Radical scavenging effect Effects 0.000 description 12
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 9
- 150000007524 organic acids Chemical class 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 235000013376 functional food Nutrition 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000013068 control sample Substances 0.000 description 6
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 235000013373 food additive Nutrition 0.000 description 5
- 239000002778 food additive Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229940093915 gynecological organic acid Drugs 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- 238000000527 sonication Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000010421 standard material Substances 0.000 description 3
- 238000003260 vortexing Methods 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000019784 crude fat Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000009048 phenolic acids Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- PANJMBIFGCKWBY-UHFFFAOYSA-N iron tricyanide Chemical compound N#C[Fe](C#N)C#N PANJMBIFGCKWBY-UHFFFAOYSA-N 0.000 description 1
- 238000000462 isostatic pressing Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 208000019180 nutritional disease Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019624 protein content Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/46—Ultra high pressure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
본 발명은 금은화(Lonicera japonica Thunb.)에 고압 처리하는 단계를 포함하는 금은화의 가공 방법 및 금은화 가공물에 관한 것이다.The present invention relates to a method for processing gold and silver coins, comprising the step of high-pressure treatment of Lonicera japonica Thunb.
Description
본 발명은 금은화(Lonicera japonica Thunb.)에 고압 처리하는 단계를 포함하는 금은화의 가공 방법 및 금은화 가공물에 관한 것이다.The present invention relates to a method for processing gold and silver coins, comprising the step of high-pressure treatment of Lonicera japonica Thunb.
생체 내에서는 에너지 생산을 위한 산화과정 중 상당량의 활성산소가 생성된다. 활성산소가 순간적으로 다량 발생되거나 만성적으로 활성산소가 발생하게 되면 세포의 구성성분과 강하게 반응하여 세포와 조직에 손상을 유발하며, 지속적인 세포의 손상은 DNA 변성, 지질 산화, 단백질 분해 등을 초래할 수 있다.In the living body, a significant amount of active oxygen is generated during the oxidation process for energy production. When active oxygen is instantaneously generated in large amounts or chronically generated, it reacts strongly with cell components to cause damage to cells and tissues, and continuous cell damage can lead to DNA denaturation, lipid oxidation, protein degradation there is.
인체 내에는 과산화물제거효소(Superoxide dismutase, SOD), 글루타티온과산화효소(glutathione peroxidase, GPX), 카탈라아제(catalase, CAT), 글루타티온환원효소(glutathione reductase), 글루타티온-S-전달효소(glutathione-S-transferase) 등과 같이 활성산소에 대항하는 항산화 효소가 존재하나, 산업화와 함께 증가하는 각종 환경오염 물질, 흡연, 스트레스 등으로 인해 인체 내의 항산화 효소 등의 활성만으로는 단백질 분해, DNA손상을 방어하는데 한계가 있다.In the human body, superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase (CAT), glutathione reductase, glutathione-S-transferase ), etc., there are antioxidant enzymes against free radicals, but due to various environmental pollutants, smoking, and stress that increase with industrialization, there is a limit to defending against protein degradation and DNA damage only with the activity of antioxidant enzymes in the human body.
항산화제로 부틸레이트하이드록시아니솔(butylated hydroxyanisole, BHA), 부틸레이트하이드록시톨루엔(butylated hydroxytoluene, BHT)과 같은 합성물질들이 개발되었으나, 인체에 대한 여러 가지 부작용을 야기할 수 있어 천연물질로부터 유래한 안전한 항산화 물질을 찾는 연구가 요구되고 있다.Synthetic substances such as butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) have been developed as antioxidants, but they can cause various side effects on the human body. Research to find safe antioxidants is required.
한편, 인류가 풍요로운 사회로 점점 발전해 감에 따라 비만이 심각한 질병 중의 하나로 등장하게 되었고 이에 세계보건기구(WHO)는 비만을 치료해야 할 질병의 대상이라고 선언하였다.On the other hand, as mankind gradually develops into an affluent society, obesity has emerged as one of the serious diseases, and the World Health Organization (WHO) has declared obesity as a disease to be treated.
비만은 열량의 섭취와 소비의 불균형으로 발생되는 대사성 질환이며, 형태학적으로 볼 때 체내 지방 세포의 크기 증가(hypertrophy) 또는 수의 증가(hyperplasia)에 의해 초래된다. 비만은 서구사회에서 가장 흔한 영양장애일 뿐만 아니라, 최근 우리나라에서도 경제발전에 의한 식생활의 향상과 생활 방식의 서구화로 비만의 빈도가 급속히 증가하는 추세에 있어서 그 치료와 예방에 대한 중요성이 크게 부각되고 있다.Obesity is a metabolic disease caused by an imbalance in calorie intake and consumption, and is morphologically caused by an increase in the size (hypertrophy) or an increase in the number (hyperplasia) of fat cells in the body. Obesity is not only the most common nutritional disorder in Western society, but also in recent years in Korea, the importance of treatment and prevention has been greatly emphasized as the frequency of obesity is rapidly increasing due to the improvement of diet and westernization of lifestyle due to economic development. there is.
상기와 같은 실정에 따라 항산화 및 항비만 활성을 증진시키기 위한 연구가 요구되고 있다.According to the circumstances as described above, research for enhancing antioxidant and anti-obesity activity is required.
본 발명의 목적은 금은화(Lonicera japonica Thunb.)에 고압 처리하는 단계를 포함하는, 금은화의 가공 방법을 제공하는 것이다.It is an object of the present invention to provide a method for processing gold and silver coins, comprising the step of high-pressure treatment for gold and silver coins ( Lonicera japonica Thunb.).
본 발명의 다른 목적은 상기 가공방법에 의하여 제조된 금은화 가공물을 제공하는 것이다.Another object of the present invention is to provide a gold-silver product manufactured by the above processing method.
본 발명의 또 다른 목적은 상기 금은화 가공물을 추출한 금은화 추출물을 제공하는 것이다.Another object of the present invention is to provide an extract of gold and silver coins obtained by extracting the processed gold and silver coins.
본 발명의 또 다른 목적은 상기 금은화 가공물 또는 금은화 추출물을 포함하는 식품 조성물을 제공하는 것이다.Another object of the present invention is to provide a food composition comprising the gold or silver flower extract or the gold and silver flower extract.
상기와 같은 목적을 달성하기 위한 본 발명의 일 측면은 금은화(Lonicera japonica Thunb.)에 고압 처리하는 단계를 포함하는, 금은화의 가공 방법을 제공한다.One aspect of the present invention for achieving the above object provides a method of processing gold and silver coins, comprising the step of high-pressure treatment of gold and silver coins ( Lonicera japonica Thunb.).
구체적으로, 상기 고압 처리는 300 MPa 내지 500 MPa에서 이루어질 수 있다. Specifically, the high pressure treatment may be performed at 300 MPa to 500 MPa.
또한 구체적으로, 상기 고압 처리는 1 분 내지 40 분 동안 이루어질 수 있다.Also specifically, the high-pressure treatment may be performed for 1 minute to 40 minutes.
또한 구체적으로, 상기 고압 처리 전에 0 ℃ 내지 10 ℃에서 방치하는 단계를 추가로 포함할 수 있으며, 상기 0 ℃ 내지 10 ℃에서 방치하는 단계는 20 시간 내지 30 시간 동안 이루어질 수 있으나 이에 제한되는 것은 아니다.In addition, specifically, the step of leaving at 0 °C to 10 °C before the high-pressure treatment may be further included, and the step of leaving at 0 °C to 10 °C may be made for 20 to 30 hours, but is not limited thereto. .
본 발명에서 “금은화(Lonicera japonica)”는 인동과(caprifoliaceae) 인동속(genus lonicera)에 속하는 인동덩굴(L. japonica Thunb.)의 꽃으로 이뇨, 건위, 관절염, 화농성 피부염, 기관지염에 효과가 알려져 있어, 의약품 또는 화장품산업에 이용되었으나, 특유의 향과 약간의 독성을 가지고 있어, 식품에 첨가될 경우 소비자의 기호도를 감소시켜 식품에 적용하기에 어려움이 있었다. In the present invention, “ Lonicera japonica ” is a flower of L. japonica Thunb. belonging to the genus lonicera of the Caprifoliaceae family, and is known to be effective in diuresis, gastric ulcer, arthritis, suppurative dermatitis, and bronchitis. Therefore, it has been used in the pharmaceutical or cosmetic industry, but has a unique flavor and slight toxicity.
본 발명에서는 금은화에 고압 처리를 함으로써 항산화 활성 및 항비만 활성이 증진되도록 하였으며, 식품에 적용할 수 있도록 하였다.In the present invention, by high-pressure treatment of gold and silver coins, antioxidant activity and anti-obesity activity were enhanced, and it was applied to food.
본 발명 일 실시예에서는 금은화에 고압 처리를 한 경우, 항비만 활성을 나타내는 페놀산, 플라보노이드 및 유기산의 함량이 증가하는 것을 확인하였으며, 고압 시간 전체에서 항산화 활성이 증진된 것을 확인하였다.In one embodiment of the present invention, it was confirmed that the content of phenolic acid, flavonoid, and organic acid exhibiting anti-obesity activity increased when high-pressure treatment was performed on gold and silver coins, and it was confirmed that the antioxidant activity was enhanced throughout the high-pressure time.
본 발명에서 사용되는 금은화는 금은화 원재료, 추출물, 분쇄물, 분산액, 분쇄액, 발효물로 이루어진 군에서 선택되는 하나 이상일 수 있으며, 이에 제한되는 것은 아니며, 필요에 따라 변형된 형태로 적용할 수 있다. 상기 '금은화 원재료'는 채취되거나 재배된 금은화 전체 또는 금은화의 일부를 말하며 가공, 추출, 분쇄 등의 단계가 수행되기 이전의 상태를 말한다.The gold and silver coins used in the present invention may be one or more selected from the group consisting of raw materials for gold and silver coins, extracts, pulverized products, dispersions, pulverized solutions, and fermented products, but is not limited thereto, and may be applied in a modified form as necessary. . The 'raw material for gold and silver coins' refers to the whole or a part of gold and silver coins that have been collected or cultivated, and refers to a state before processing, extraction, and pulverization are performed.
본 발명의 다른 측면은 상기 가공 방법에 의하여 제조된 금은화 가공물을 제공한다.Another aspect of the present invention provides a gold-silver product manufactured by the above processing method.
구체적으로 상기 금은화 가공물은 항산화 또는 항비만 활성이 증진된 것일 수 있으며, 클로로겐산(chlorogenic acid), 카페익산(caffeic acid), 4,5-디카페오일퀸산(4,5-dicaffeoylquinic acid), 3,5-디카페오일퀸산(3,5-dicaffeoylquinic acid), 루틴(rutin), 퀘르세틴(quercetin), 루테올린(luteolin), 퀸산(quinic acid) 및 시킴산(shikimic acid)으로 이루어진 군에서 선택되는 하나 이상의 화합물의 함량이 증가된 것을 특징으로 할 수 있다.Specifically, the processed gold and silver coins may have enhanced antioxidant or anti-obesity activity, and chlorogenic acid, caffeic acid, 4,5-dicaffeoylquinic acid, 3, 5-dicaffeoyl quinic acid (3,5-dicaffeoylquinic acid), rutin (rutin), quercetin (quercetin), luteolin (luteolin), quinic acid (quinic acid) and one selected from the group consisting of shikimic acid (shikimic acid) It may be characterized in that the content of the above compounds is increased.
본 발명 일 실시예에서는 금은화에 고압 처리를 할 경우, 항비만 활성을 나타내는 페놀산인 클로로겐산, 카페익산, 4,5-디카페오일퀸산 및 3,5-디카페오일퀸산이 증가하고, 플라보노이드인 루틴, 퀘르세틴 및 루테올린이 증가하는 것을 확인하였다(표 5). 또한, 고압 시간 전체에서 DPPH 라디칼 소거능, ABTS 라디칼 소거능, FRAP(Ferric reducing antioxidant power) 값 및 환원력이 증가함을 확인하여 항산화 활성 역시 증진되었음을 확인하였다(도 3 내지 도 6). In one embodiment of the present invention, when high-pressure treatment is performed on gold and silver coins, chlorogenic acid, caffeic acid, 4,5-dicaffeoylquinic acid, and 3,5-dicaffeoylquinic acid, which are phenolic acids showing antiobesity activity, increase, and the flavonoid rutin , it was confirmed that quercetin and luteolin increased (Table 5). In addition, it was confirmed that antioxidant activity was also enhanced by confirming that DPPH radical scavenging ability, ABTS radical scavenging ability, ferric reducing antioxidant power (FRAP) value and reducing power were increased throughout the high pressure time ( FIGS. 3 to 6 ).
상기 클로로겐산은 카페익산 및 퀸산의 에스테르 결합으로 이루어진 물질로, 과산화지질의 생성 억제, 콜레스테롤 생합성 억제, 항산화, 항암 및 항비만 효과가 있는 것으로 알려져 있다. 식물에 존재하는 클로로겐산은 클로로겐산의 카르복실기와 세포벽의 탄수화물과 단백질과 에스테르 결합을 이루고, 클로로겐산의 하이드록실기는 리그닌과 에테르 결합을 이루고 있다. 고압 처리시 이들 결합이 파괴됨으로써 결합되어 있던 클로로겐산이 유리되어 함량이 증가할 수 있다.The chlorogenic acid is a substance composed of an ester bond of caffeic acid and quinic acid, and is known to have effects of inhibiting the production of lipid peroxide, inhibiting cholesterol biosynthesis, antioxidant, anti-cancer and anti-obesity. Chlorogenic acid present in plants forms an ester bond with the carboxyl group of chlorogenic acid with carbohydrates and proteins in the cell wall, and the hydroxyl group of chlorogenic acid forms an ether bond with lignin. When these bonds are broken during high-pressure treatment, the bound chlorogenic acid may be released and the content may increase.
또한, 디카페오일퀸산은 퀸산에 2개의 카페익산이 에스테르결합으로 이루어진 물질로서, 금은화에 존재하는 4,5-디카페오일퀸산과 3,5-디카페오일퀸산의 카페익산이 고압 처리시 부분적으로 가수분해되어 클로로겐산으로 전환되어 함량이 증가할 수 있다.In addition, decaffeoyl quinic acid is a substance consisting of ester bonds of two caffeic acids to quinic acid, and the caffeic acid of 4,5-dicaffeoylquinic acid and 3,5-dicaffeoylquinic acid present in gold and silver coins is partially dissolved during high pressure treatment. It can be hydrolyzed to chlorogenic acid to increase the content.
상기 카페익산은 카볼산(carbolic acid)이라고도 하며, 발암억제제 또는 항산화제로도 알려져 있으며, 금은화 추출물의 카페익산 함량은 추출 전 고압 처리 공정에 의해 현저히 증대될 수 있다.The caffeic acid is also called carbolic acid, and is also known as a carcinogen or antioxidant.
상기 퀸산은 클로로겐산, 4,5-디카페오일퀸산 및 3,5-디카페오일퀸산의 가수분해 산물로, 금은화의 고압 처리에 의해 상기 클로로겐산, 4,5-디카페오일퀸산 및 3,5-디카페오일퀸산이 가수분해되어 퀸산의 함량이 증대될 수 있다.The quinic acid is a hydrolysis product of chlorogenic acid, 4,5-dicaffeoylquinic acid and 3,5-dicaffeoylquinic acid, and the chlorogenic acid, 4,5-dicaffeoylquinic acid and 3,5-dicaffeoylquinic acid and 3,5- Decaffeoyl quinic acid may be hydrolyzed to increase the content of quinic acid.
상기 시킴산은 퀸산의 유도체로서, 금은화의 고압 처리에 의해 상기 퀸산이 가수분해되어 퀸산 락톤 또는 시킴산으로 전환될 수 있으므로, 상기 시킴산의 함량이 증대될 수 있다.The shikimic acid is a derivative of quinic acid, and since the quinic acid is hydrolyzed by high-pressure treatment of gold and silver coins to be converted into lactone quinic acid or shikimic acid, the content of the shikimic acid can be increased.
본 발명의 또 다른 측면은 상기 금은화 가공물을 열수 또는 유기용매로 추출한 금은화 추출물을 제공한다.Another aspect of the present invention provides an extract of gold and silver coins obtained by extracting the processed gold and silver coins with hot water or an organic solvent.
상기 “추출물”은 용매와 추출재료를 특정 조건하에서 접촉시킴으로써 추출재료에 함유된 유효성분을 분리해낸 것으로, 상기 추출물은 금은화 추출물에 대한 추출 공정에 의해 원료 내의 유효성분을 포함할 수 있다.The "extract" is obtained by separating the active ingredients contained in the extracting material by contacting the solvent and the extracting material under specific conditions, and the extract may include the active ingredient in the raw material by the extraction process for the gold and silver extract.
상기 금은화 추출물은 천연물로부터 추출물을 추출하는 당업계에 공지된 통상적인 방법에 따라, 즉, 통상적인 온도, 압력의 조건 하에서 통상적인 용매를 사용하여 추출할 수 있다. 예컨대, 상기 금은화 추출물은 물, 알코올, 에틸아세테이트, 아세톤, 핵산, 디클로로메탄 또는 이들의 혼합 용매를 사용하여 추출할 수 있으며, 이는 필요에 따라 변형하여 적용할 수 있다.The gold and silver extract can be extracted according to a conventional method known in the art for extracting an extract from a natural product, that is, using a conventional solvent under conditions of conventional temperature and pressure. For example, the gold and silver flower extract may be extracted using water, alcohol, ethyl acetate, acetone, nucleic acid, dichloromethane, or a mixed solvent thereof, which may be modified and applied as necessary.
상기 추출 방법은 열수 추출, 냉침 추출, 환류 추출, 초음파 추출 등의 다양한 방법을 사용할 수 있으며, 바람직하게는 열수 추출을 사용할 수 있으나 이에 제한되는 것은 아니다.As the extraction method, various methods such as hot water extraction, cold extraction, reflux extraction, and ultrasonic extraction may be used, and hot water extraction may be preferably used, but is not limited thereto.
또한, 금은화 추출물을 기초로 고압 처리를 하여 금은화 가공물을 제공한 경우라도 당업자의 필요에 따라 재추출 과정을 거칠 수 있다.In addition, even when the gold and silver coins are processed by high-pressure treatment based on the gold and silver extract, a re-extraction process may be performed according to the needs of those skilled in the art.
본 발명의 금은화 가공물은 고압 처리를 통하여 항산화 또는 항비만 활성이 증진되었는 바, 이를 이용하여 추출물을 제조함으로써 항산화 또는 항비만 활성이 증진된 금은화 추출물이 제공될 수 있다. Since the anti-oxidation or anti-obesity activity of the processed gold and silver flower of the present invention is enhanced through high-pressure treatment, an extract of the gold and silver flower with enhanced antioxidant or anti-obesity activity can be provided by preparing an extract using the same.
본 발명의 또 다른 측면은 상기 금은화 가공물 또는 금은화 추출물을 포함하는 식품 조성물을 제공한다. 구체적으로, 상기 식품 조성물은 항산화 또는 항비만 활성을 나타내는 것일 수 있다.Another aspect of the present invention provides a food composition comprising the processed gold and silver coins or an extract of gold and silver coins. Specifically, the food composition may exhibit antioxidant or anti-obesity activity.
본 발명 일 실시예에서는 금은화에 고압 처리를 함으로써 금은화의 항산화 활성이 증진된 것을 확인하였으며(도 3 내지 도 6), 항비만 활성을 나타내는 것으로 알려진 페놀산 및 플라보노이드의 함량이 증가되는 것을 확인하였다(표 3 및 표5).In one embodiment of the present invention, it was confirmed that the antioxidant activity of the gold and silver coins was enhanced by high-pressure treatment (FIGS. 3 to 6), and it was confirmed that the contents of phenolic acid and flavonoids, which are known to exhibit anti-obesity activity, were increased ( Table 3 and Table 5).
상기 식품 조성물은 식품학적으로 허용가능한 담체를 포함할 수 있다.The food composition may include a food pharmaceutically acceptable carrier.
본 발명의 식품 조성물은 기능성 식품(functional food), 영양 보조제(nutritional supplement), 건강 식품(health food) 및 식품 첨가제(food additives)등의 모든 형태를 포함하여, 상기 유형의 식품 조성물은 당업계에 공지된 통상적인 방법에 따라 다양한 형태로 제조할 수 있다.The food composition of the present invention includes all forms of functional food, nutritional supplement, health food and food additives, etc., food compositions of this type are known in the art. It can be prepared in various forms according to known conventional methods.
본 발명은 금은화 가공물 또는 금은화 추출물을 식품 첨가물로 사용할 경우, 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 사용 목적 (예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다.In the present invention, when the processed gold and silver flower or the gold and silver flower extract is used as a food additive, it may be added as it is or used together with other foods or food ingredients, and may be appropriately used according to a conventional method. The mixing amount of the active ingredient may be appropriately determined depending on the purpose of use (prophylactic, health or therapeutic treatment).
상기 식품의 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the type of the food. Examples of foods to which the above substances can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, various soups, beverages, tea, drinks, There are alcoholic beverages, vitamin complexes, and the like, and includes all health foods in the ordinary sense.
상기 외에 본 발명의 식품 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 천연 과일주스, 과일주스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 또한, 상기 식품은 공지의 제조방법에 따라 정제, 과립, 분말, 캅셀, 액상의 용액 및 환 등의 제형으로도 제조될 수 있다. 또한, 통상의 여러가지 향미제 또는 천연 탄수화물 등을 추가성분으로서 포함할 수 있다.In addition to the above, the food composition of the present invention includes various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol , a carbonation agent used in carbonated beverages, and the like. In addition, it may contain the pulp for the production of natural fruit juice, fruit juice beverage and vegetable beverage. These components may be used independently or in combination. In addition, the food can be prepared in the form of tablets, granules, powders, capsules, liquid solutions and pills according to known manufacturing methods. In addition, various conventional flavoring agents or natural carbohydrates may be included as additional ingredients.
또한 구체적으로, 상기 식품 조성물은 건강기능식품일 수 있다.Also specifically, the food composition may be a health functional food.
상기 건강기능식품은 건강기능식품에 관한 법률 제6727호에 따른 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 제조 및 가공한 식품을 말하며, 인체의 구조 및 기능에 대하여 영양소를 조절하거나 생리학적 작용 등과 같은 보건 용도에 유용한 효과를 얻을 목적으로 섭취하는 것을 말한다. 본 발명의 건강기능식품은 통상의 식품 첨가물을 포함할 수 있으며, 식품 첨가물로서의 적합 여부는 다른 규정이 없는 한, 식품의약품안전처에 승인된 식품 첨가물 공전의 총칙 및 일반시험법 등에 따라 해당 품목에 관한 규격 및 기준에 의하여 판정한다.The health functional food refers to a food manufactured and processed using raw materials or ingredients useful for the human body according to the Health Functional Food Act No. 6727, and controls nutrients or physiological action for the structure and function of the human body. It refers to ingestion for the purpose of obtaining useful effects for health purposes such as The health functional food of the present invention may contain normal food additives, and the suitability as a food additive is determined according to the general rules and general test methods of food additives approved by the Ministry of Food and Drug Safety, etc., unless otherwise specified. It is judged according to the relevant standards and standards.
본 발명의 가공방법에 의해 제조된 금은화 가공물 또는 금은화 추출물을 포함하는 건강기능식품 또는 건강기능 음료에 포함하여 사용할 경우, 상기 화합물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용하고, 통상적인 방법에 따라 적절하게 사용할 수 있다. 또한, 혼합량은 그의 사용 목적(예방, 건강 또는 개선, 치료적 처치)에 따라 적합하게 결정될 수 있다.When used as a health functional food or health functional beverage containing a processed gold and silver flower or an extract of gold and silver coins produced by the processing method of the present invention, the compound is added as it is or used with other foods or food ingredients, and is used in a conventional method. can be used appropriately. In addition, the mixing amount may be appropriately determined depending on the intended use thereof (prevention, health or improvement, therapeutic treatment).
본 발명의 고압 처리 방법을 통해 금은화의 항산화 또는 항비만 활성을 증진시킬 수 있으며, 이에 의해 제조된 금은화 가공물 및 금은화 추출물은 항산화 또는 항비만용 식품 조성물로 활용될 수 있다.The high-pressure treatment method of the present invention can enhance the antioxidant or anti-obesity activity of gold and silver coins, and the processed gold and silver coins and extracts of gold and silver coins prepared thereby can be utilized as antioxidant or anti-obesity food compositions.
본 발명의 효과는 상기한 효과로 한정되는 것은 아니며, 본 발명의 상세한 설명 또는 청구범위에 기재된 발명의 구성으로부터 추론 가능한 모든 효과를 포함하는 것으로 이해되어야 한다.It should be understood that the effects of the present invention are not limited to the above-described effects, and include all effects that can be inferred from the configuration of the invention described in the detailed description or claims of the present invention.
도 1은 본 발명의 실시예 및 대조군 시료의 페놀산 및 플라보노이드 함량을 RP-HPLC를 통해 분석한 결과로, 구체적으로, (1)은 클로로겐산, (2)는 카페익산, (3)은 4,5-디카페오일퀸산, (4)는 3,5-디카페오일퀸산, (5)는 루틴, (6)은 퀘르세틴 그리고 (7)은 루테올린이다.
도 2는 본 발명의 실시예 및 대조군의 유기산 함량을 HPLC를 통해 분석한 결과이다.
도 3은 본 발명의 실시예 및 대조군 시료의 DPPH 라디칼 소거능을 측정한 결과이다.
도 4는 본 발명의 실시예 및 대조군 시료의 ABTS 라디칼 소거능을 측정한 결과이다.
도 5는 본 발명의 실시예 및 대조군 시료의 FRAP(Ferric reducing antioxidant power)를 측정한 결과이다.
도 6은 본 발명의 실시예 및 대조군 시료의 환원력을 측정한 결과이다.1 is a result of analyzing the phenolic acid and flavonoid content of Examples and control samples of the present invention through RP-HPLC, specifically, (1) is chlorogenic acid, (2) is caffeic acid, (3) is 4, 5-dicaffeoylquinic acid, (4) is 3,5-dicaffeoylquinic acid, (5) is rutin, (6) is quercetin, and (7) is luteolin.
2 is a result of analyzing the organic acid content of Examples and Controls of the present invention through HPLC.
3 is a result of measuring the DPPH radical scavenging ability of the Example and the control sample of the present invention.
4 is a result of measuring the ABTS radical scavenging ability of the Example and the control sample of the present invention.
5 is a result of measuring ferric reducing antioxidant power (FRAP) of the examples and control samples of the present invention.
6 is a result of measuring the reducing power of the Example and the control sample of the present invention.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of Examples. However, the following examples only illustrate the present invention, and the present invention is not limited by the following examples.
금은화의 일반 성분 분석Analysis of the general composition of gold and silver coins
금은화의 일반 성분은 AOAC 방법에 따라 수분, 조회분, 조지방, 조단백질 함량을 분석하였으며, 탄수화물은 100에서 이들 함량을 뺀 값으로 하였다.For general components of gold and silver coins, moisture, crude flour, crude fat, and crude protein contents were analyzed according to the AOAC method, and carbohydrates were calculated by subtracting these contents from 100.
하기 표 1에 나타난 바와 같이, 금은화의 수분함량은 6.06 %, 조회분 함량은 6.20 %, 조지방 함량은 3.77 %, 단백질 함량은 10.35 % 그리고 탄수화물 함량은 73.62 %로 나타났다.As shown in Table 1 below, the moisture content of gold and silver coins was 6.06%, the crude flour content was 6.20%, the crude fat content was 3.77%, the protein content was 10.35%, and the carbohydrate content was 73.62%.
제조예 1. 금은화 고압 처리Preparation Example 1. High pressure treatment of gold and silver coins
금은화 12 g을 4 °C에서 24 시간 동안 방치 후, vacuum sealer(SW-600, MAgic Seal, Gyeonggi-do, South Korea)를 이용해 진공포장한 후, isostatic pressing machine(CIP22260, Avure Technologies Inc., Lewis center, OH, USA)을 이용해 400 MPa에서 압력 시간을 달리하여 고압 처리하였다.After standing at 4 °C for 24 hours, 12 g of gold and silver coins were vacuum-packed using a vacuum sealer (SW-600, MAgic Seal, Gyeonggi-do, South Korea), followed by an isostatic pressing machine (CIP22260, Avure Technologies Inc., Lewis). center, OH, USA) at 400 MPa for different pressure times and high pressure treatment.
구체적으로, 각각 1, 5, 10, 20 및 40분씩 고압 처리하였으며, 순서대로 각각 실시예 1(1 분 고압 처리), 실시예 2(5 분 고압 처리), 실시예 3(10 분 고압 처리), 실시예 4(20 분 고압 처리) 및 실시예 5(40분 고압 처리)로 명명하였다.Specifically, high pressure treatment was carried out for 1, 5, 10, 20 and 40 minutes, respectively, in order, Example 1 (1 minute high pressure treatment), Example 2 (5 minute high pressure treatment), Example 3 (10 minute high pressure treatment), respectively , Example 4 (20 min high pressure treatment) and Example 5 (40 min high pressure treatment).
실험예 1. 고압 처리한 금은화의 이화학적 특성 분석Experimental Example 1. Analysis of Physicochemical Characteristics of Gold and Silver Coins Treated with High Pressure
1-1. 고압 처리한 금은화의 색도 분석1-1. Chromaticity analysis of high-pressure treated gold and silver coins
상기 고압 처리한 금은화의 이화학적 특성을 분석하기 위해 색도를 분석하였으며, 고압 처리하지 않은 금은화를 대조군으로 하였다.In order to analyze the physicochemical properties of the high-pressure-treated gold and silver coins, the chromaticity was analyzed, and the high-pressure-treated gold and silver coins were used as a control.
상기 금은화의 색도 분석은 Minolta Chroma Meter CR-400 (Konica Minolta, Tokyo, Japan)을 이용하여 측정하였으며, 결과는 L* (명도), a* (적색도), b* (황색도), ΔE (총색차), H˚ (색상각) 및 C* (채도)로 나타내었다.The chromaticity analysis of the gold and silver coins was measured using a Minolta Chroma Meter CR-400 (Konica Minolta, Tokyo, Japan), and the results were L * (brightness), a * (redness), b * (yellowness), ΔE ( total color difference), H ˚ (color angle), and C * (saturation).
ΔE, H˚ 및 C*는 하기 수식 1 내지 3으로 측정하였다(표 2).ΔE, H˚ and C* were measured by
[수식 1][Formula 1]
ΔE = [(ΔL*)2 + (Δa*)2 + (Δb*)2]0.5 ΔE = [( ΔL *) 2 + ( Δa *) 2 + ( Δb *) 2 ] 0.5
[수식 2][Equation 2]
H˚ = tan-1 (b*/a*) H˚ = tan -1 ( b* / a* )
[수식 3][Equation 3]
C* = [(a*)2 + (b*)2]0.5 C* = [( a* ) 2 + ( b* ) 2 ] 0.5
구분
division
색도
chromaticity
L*
L *
a*
a *
b*
b *
△E
△ E
H°
H °
C*
C *
대조군
control
38.62 ± 1.00a1)
38.62 ± 1.00 a1)
2.60 ± 0.03a
2.60 ± 0.03 a
19.47 ± 0.18a
19.47 ± 0.18 a
-
-
82.43 ± 0.06c
82.43 ± 0.06 c
19.64 ± 0.18a
19.64 ± 0.18 a
실시예 1
Example 1
39.84 ± 0.98a
39.84 ± 0.98 a
1.87 ± 0.06b
1.87 ± 0.06 b
19.84 ± 0.30a
19.84 ± 0.30 a
1.82 ± 0.33a
1.82 ± 0.33 a
84.65 ± 0.24a
84.65 ± 0.24 a
19.92 ± 0.29a
19.92 ± 0.29 a
실시예 2
Example 2
39.37 ± 0.31a
39.37 ± 0.31 a
1.98 ± 0.04b
1.98 ± 0.04 b
19.78 ± 0.05a
19.78 ± 0.05 a
1.21 ± 0.10a
1.21 ± 0.10 a
84.33 ± 0.12ab
84.33 ± 0.12 ab
19.88 ± 0.05a
19.88 ± 0.05 a
실시예 3
Example 3
39.20 ± 1.56a
39.20 ± 1.56 a
1.93 ± 0.04b
1.93 ± 0.04 b
19.33 ± 0.48a
19.33 ± 0.48 a
1.59 ± 0.26a
1.59 ± 0.26 a
84.34 ± 0.04ab
84.34 ± 0.04 ab
19.42 ± 0.48a
19.42 ± 0.48 a
실시예 4
Example 4
40.17 ± 1.00a
40.17 ± 1.00 a
1.92 ± 0.11b
1.92 ± 0.11 b
19.93 ± 0.36a
19.93 ± 0.36 a
1.53 ± 0.61a
1.53 ± 0.61 a
84.54 ± 0.23ab
84.54 ± 0.23 ab
20.02 ± 0.36a
20.02 ± 0.36 a
실시예 5
Example 5
39.23 ± 0.98a
39.23 ± 0.98 a
2.00 ± 0.12b
2.00 ± 0.12 b
19.59 ± 0.80a
19.59 ± 0.80 a
1.44 ± 0.16a
1.44 ± 0.16 a
84.21 ± 0.29b
84.21 ± 0.29 b
19.69 ± 0.80a
19.69 ± 0.80 a
*동일 컬럼 내의 동일 알파벳 문자가 붙은 값은 유의적 차이를 보이지 않음(p<0.05)
* Values with the same alphabetic character in the same column do not show a significant difference (p<0.05)
표 2를 참조하면, 고압 처리는 L*, b* 및 C* 값에는 영향을 미치지 않았다.Referring to Table 2, the high pressure treatment did not affect the L*, b* and C * values.
a* 값은 실시예 1 내지 5의 실시예에서 대조군보다 유의적으로 낮아졌으며, 고압 처리 시간에 의한 영향은 나타나지 않았다. 이는 고압 처리에 의해 금은화의 클로로필 함량이 유의적으로 높아져 적색도가 낮아져 a* 값이 감소한 것으로 볼 수 있다.The a* value was significantly lower than that of the control group in Examples 1 to 5, and there was no effect due to the high pressure treatment time. It can be seen that the high-pressure treatment significantly increased the chlorophyll content of the gold and silver coins and lowered the redness, thereby reducing the a* value.
상기 클로로필은 중심에 마그네슘을 가지고 있으며, 상기 마그네슘은 항산화 기작에 관여한다고 알려져 있으므로, 상기 결과는 고압 처리로 클로로필 함량이 증가한 금은화에 항산화 활성이 있음을 시사한다.The chlorophyll has magnesium at the center, and since it is known that the magnesium is involved in the antioxidant mechanism, the above results suggest that gold and silver coins having an increased chlorophyll content through high-pressure treatment have antioxidant activity.
ΔE는 값이 5가 넘어가면 사람이 눈으로 대조군과 색 차이가 나는 것으로 뚜렷하게 인지할 수 있는데, 실시예 1 내지 5의 실시예에서 ΔE 값은 모두 5보다 낮았다.When the value of ΔE exceeds 5, the human eye can clearly recognize that the color is different from the control. In Examples 1 to 5, ΔE values were all lower than 5.
상기 결과는 금은화를 고압 처리 하더라도 원래의 색을 어느정도 유지할 수 있었으며, 관능적 품질 특성을 보존할 수 있음을 시사한다.The above result suggests that the original color could be maintained to some extent even when the gold and silver coins were subjected to high pressure treatment, and the sensory quality characteristics could be preserved.
1-2. 고압 처리한 금은화의 총 페놀산(phenolic acid) 및 플라보노이드(flavonoid) 함량 분석1-2. Analysis of total phenolic acid and flavonoid content of high-pressure treated gold and silver coins
상기 고압 처리한 금은화의 이화학적 특성을 분석하기 위해 총 페놀산 및 플라보노이드의 함량을 분석하였다.In order to analyze the physicochemical properties of the high-pressure-treated gold and silver coins, the contents of total phenolic acid and flavonoids were analyzed.
구체적으로, 상기 금은화의 총 페놀산 함량은 Folin-Ciocalteau 방법을 변형하여 측정하였다.Specifically, the total phenolic acid content of the gold and silver coins was measured by modifying the Folin-Ciocalteau method.
0.1 g의 실시예 및 대조군 시료에 70 % (v/v) 메탄올 10 mL을 가한 후, 1 분간 교반하였다. 이후, 30 분간 소니케이션 후 3,500 rpm에서 20 분간 원심분리하였다. 상등액은 증류수를 이용해 5 배 희석하였고, 0.5 mL 시료액에 1 N Folin 시약 0.5 mL를 가한 후 3 분 뒤 10 % (w/v) Na2CO3 용액 1.5 mL를 가하였다. 이후 암실에서 1 시간 보관 후 725 nm에서 흡광도를 측정하였고, 갈산(gallic acid, GAE)을 스탠다드로 사용하였다.After adding 10 mL of 70% (v/v) methanol to 0.1 g of the example and control samples, the mixture was stirred for 1 minute. Thereafter, after sonication for 30 minutes, centrifugation was performed at 3,500 rpm for 20 minutes. The supernatant was diluted 5 times with distilled water, 0.5 mL of 1 N Folin reagent was added to the 0.5 mL sample solution, and after 3 minutes, 1.5 mL of a 10% (w/v) Na 2 CO 3 solution was added. After storage in the dark for 1 hour, absorbance was measured at 725 nm, and gallic acid (GAE) was used as a standard.
또한, 상기 금은화의 총 플라보노이드 함량은 aluminum chloride colorimetric method 방법을 변형하여 측정하였다.In addition, the total flavonoid content of the gold and silver coins was measured by modifying the aluminum chloride colorimetric method.
0.1 g의 실시예 및 대조군 시료에 70% (v/v) 메탄올 10 mL을 가한 후, 1분간 교반하였다. 이후, 30분간 소니케이션 후 3,500 rpm에서 20분간 원심분리하였다. 상등액은 70% (v/v) 메탄올을 이용해 5 배 희석하였고, 0.3 mL 시료액에 증류수 0.3 mL 및 5 % (w/v) NaNO2 30 uL를 가하였다. 5 분 후, 10 % (w/v) AlCl3 60 uL를 가하였고, 5분 후 1 M NaOH 200 uL를 가하였다. 이후 500 nm에서 흡광도를 측정하였고, 루틴(rutin, RE)을 스탠다드로 사용하였다(표 3).After adding 10 mL of 70% (v/v) methanol to 0.1 g of the example and control samples, the mixture was stirred for 1 minute. Thereafter, after sonication for 30 minutes, centrifugation was performed at 3,500 rpm for 20 minutes. The supernatant was diluted 5 times with 70% (v/v) methanol, and 0.3 mL of distilled water and 30 uL of 5% (w/v) NaNO 2 were added to the 0.3 mL sample solution. After 5 minutes, 60 uL of 10% (w/v) AlCl 3 was added, and after 5 minutes, 200 uL of 1 M NaOH was added. Then, absorbance was measured at 500 nm, and rutin (RE) was used as a standard (Table 3).
(ug GAE/100 mg)Total phenolic acid content
(ug GAE/100 mg)
(ug RE/100 mg)Total flavonoid content
(ug RE/100 mg)
상기 표 3에 나타난 바와 같이, 대조군의 총 페놀 및 총 플라보노이드 함량은 각각 2013.08 ug GAE/100mg, 4494.79 ug RE/100mg으로 나타났다. 반면, 실시예 1 내지 5의 총 페놀산 및 플라보노이드 함량은 대조군에 비해 유의적으로 증가하였고, 특히, 실시예 2의 총 페놀산 및 플라보노이드 함량은 최대치를 나타내었다(각각 2203.94 ug GAE/100 mg 및 5206.60 ug RE/100 mg). 상기 결과는 열처리에 의해 세포벽이 파괴되어 세포벽과 결합되어 있던 페놀 물질들이 유리된 상태로 전환됨에 기인한 것이라 할 수 있다.As shown in Table 3 above, the total phenol and total flavonoid contents of the control group were found to be 2013.08 ug GAE/100mg and 4494.79 ug RE/100mg, respectively. On the other hand, the total phenolic acid and flavonoid contents of Examples 1 to 5 were significantly increased compared to the control group, and in particular, the total phenolic acid and flavonoid contents of Example 2 showed maximum values (2203.94 ug GAE/100 mg and 5206.60 ug RE/100 mg). The above result can be attributed to the cell wall being destroyed by heat treatment, and the phenolic substances bound to the cell wall are converted to a free state.
1-3. 고압 처리한 금은화의 RP-HPLC를 이용한 페놀산 및 플라보노이드 함량 분석1-3. Analysis of phenolic acid and flavonoid content using RP-HPLC of high-pressure-treated gold and silver coins
상기 고압 처리한 금은화의 이화학적 특성을 분석하기 위해 페놀산 및 플라보노이드의 함량을 분석하였다.The content of phenolic acid and flavonoids was analyzed in order to analyze the physicochemical properties of the high-pressure treated gold and silver coins.
구체적으로, 0.1 g의 실시예 및 대조군 시료에 70 %(v/v) 메탄올 5 mL를 가한 후, 1분간 볼텍싱하고 30분간 소니케이션 후 3,500 rpm에서 20분간 원심분리하였다. 상등액은 0.45 um membrane filter (Millipore, Ireland)로 필터링하여 준비하였고, Aglient 1200 HPLC system(Aglient Technologies, Palo Alto, USA)를 이용하여 하기 표 4의 조건에서 페놀산 및 플라보노이드의 함량을 분석하였다(도 1 및 표 5). 금은화의 페놀산과 플라보노이드 정량평가를 위한 각각의 물질의 농도 범위는 10-500, 0.1-10, 1-100, 10-250, 1-50, 0.1-5, 및 0.1-10 ug/mL로 설정하였다.Specifically, after adding 5 mL of 70% (v/v) methanol to 0.1 g of Example and Control samples, vortexing for 1 minute, sonication for 30 minutes, and centrifugation at 3,500 rpm for 20 minutes. The supernatant was prepared by filtering with a 0.45 um membrane filter (Millipore, Ireland), and the contents of phenolic acid and flavonoids were analyzed using the Aglient 1200 HPLC system (Aglient Technologies, Palo Alto, USA) under the conditions of Table 4 below (Fig. 1 and Table 5). The concentration ranges of each substance for quantitative evaluation of phenolic acid and flavonoids of gold and silver coins were set to 10-500, 0.1-10, 1-100, 10-250, 1-50, 0.1-5, and 0.1-10 ug/mL. .
페놀산은 클로로겐산(chlorogenic acid), 카페익산(caffeic acid), 4,5-디카페오일퀸산(4,5-dicaffeoylquinic acid) 및 3,5-디카페오일퀸산(3,5-dicaffeoylquinic acid)을, 플라보노이드는 루틴(rutin), 퀘르세틴(quercetin) 및 루테올린(luteolin)을 스탠다드 물질로 사용하였고, 이는 모두 항비만과 연관이 있는 물질로 알려져 있다.Phenolic acid is chlorogenic acid, caffeic acid, 4,5-dicaffeoylquinic acid and 3,5-dicaffeoylquinic acid, As flavonoids, rutin, quercetin and luteolin were used as standard substances, all of which are known to be anti-obesity-related substances.
0-30 min: 30-60% B.Phosphoric acid (A: 0.2%, v/v) and methanol (B)
0-30 min: 30-60% B.
구분
division
페놀산 함량(ug/100 mg)
Phenolic acid content (ug/100 mg)
플라보노이드 함량(ug/100 mg)
Flavonoid content (ug/100 mg)
클로로겐산
chlorogenic acid
카페익산
caffeic acid
4,5-디카페오일퀸산
4,5-decaffeoyl quinic acid
3,5-디카페오일퀸산
3,5-decafoil quinic acid
루틴
Routine
퀘르세틴
quercetin
루테올린
luteolin
대조군
control
1006.51 ± 37.31c1)
1006.51 ± 37.31 c1)
1.92 ± 0.12d
1.92 ± 0.12 d
13.38 ± 0.43c
13.38 ± 0.43 c
648.77 ± 21.31c
648.77 ± 21.31 c
36.07 ± 2.51c
36.07 ± 2.51 c
6.49 ± 0.34d
6.49 ± 0.34 d
0.09 ± 0.02c
0.09 ± 0.02 c
실시예 1
Example 1
1145.11 ± 46.70b
1145.11 ± 46.70 b
2.12 ± 0.15cd
2.12 ± 0.15 cd
15.50 ± 0.77b
15.50 ± 0.77 b
765.47 ± 39.18b
765.47 ± 39.18 b
39.51 ± 0.80b
39.51 ± 0.80 b
7.86 ± 0.32b
7.86 ± 0.32 b
0.11 ± 0.01b
0.11 ± 0.01 b
실시예 2
Example 2
1244.69 ± 15.84a
1244.69 ± 15.84 a
2.60 ± 0.07a
2.60 ± 0.07 a
17.20 ± 0.27a
17.20 ± 0.27 a
833.76 ± 14.50a
833.76 ± 14.50 a
43.60 ± 0.22a
43.60 ± 0.22 a
7.85 ± 0.48b
7.85 ± 0.48 b
0.15 ± 0.01a
0.15 ± 0.01 a
실시예 3
Example 3
1241.15 ± 29.47a
1241.15 ± 29.47 a
2.50 ± 0.10ab
2.50 ± 0.10 ab
17.73 ± 0.79a
17.73 ± 0.79 a
837.64 ± 34.57a
837.64 ± 34.57 a
42.32 ± 0.06ab
42.32 ± 0.06 ab
8.35 ± 0.20a
8.35 ± 0.20 a
0.13 ± 0.02ab
0.13 ± 0.02 ab
실시예 4
Example 4
1229.58 ± 44.74a
1229.58 ± 44.74 a
2.30 ± 0.15bc
2.30 ± 0.15 bc
17.39 ± 0.73a
17.39 ± 0.73 a
825.50 ± 28.85a
825.50 ± 28.85 a
42.89 ± 3.45a
42.89 ± 3.45 a
7.92 ± 0.10b
7.92 ± 0.10 b
0.11 ± 0.01b
0.11 ± 0.01 b
실시예 5
Example 5
1159.08 ± 0.31b
1159.08 ± 0.31 b
2.10 ± 0.11cd
2.10 ± 0.11 cd
16.14 ± 0.03b
16.14 ± 0.03 b
762.78 ± 3.32b
762.78 ± 3.32 b
40.66 ± 0.65ab
40.66 ± 0.65 ab
6.93 ± 0.14c
6.93 ± 0.14 c
0.12 ± 0.01b
0.12 ± 0.01 b
*동일 컬럼 내의 동일 알파벳 문자가 붙은 값은 유의적 차이를 보이지 않음(p<0.05)
* Values with the same alphabetic character in the same column do not show a significant difference (p<0.05)
도 1에 나타난 바와 같이, 금은화에는 페놀산(클로로겐산, 카페익산, 4,5-디카페오일퀸산 및 3,5-디카페오일퀸산) 및 플라보노이드(루틴, 퀘르세틴 및 루테올린)이 포함되어 있음을 확인하였다. 클로로겐산은 금은화의 주요한 물질 중 하나로, 카페익산과 퀸산의 에스테르 결합으로 이루어져 있다. As shown in Figure 1, gold and silver coins contain phenolic acids (chlorogenic acid, caffeic acid, 4,5-dicaffeoylquinic acid and 3,5-dicaffeoylquinic acid) and flavonoids (rutin, quercetin and luteolin). Confirmed. Chlorogenic acid is one of the main substances of gold and silver coins, and is composed of an ester bond between caffeic acid and quinic acid.
표 5에 나타난 바와 같이, 금은화의 페놀산 및 플라보노이드 함량은 고압 처리 시간 전체에서 유의적으로 증가하였다(실시예2).As shown in Table 5, the phenolic acid and flavonoid contents of the gold coins were significantly increased throughout the high pressure treatment time (Example 2).
특히, 클로로겐산, 카페익산, 4,5-디카페오일퀸산, 3,5-디카페오일퀸산, 루틴, 루테올린의 함량은 5분 고압 처리시 최대 함량을 보였고, 퀘르세틴은 10분 고압 처리시 최대 함량을 나타내었다.In particular, the contents of chlorogenic acid, caffeic acid, 4,5-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, rutin, and luteolin showed the maximum content at the time of high pressure treatment for 5 minutes, and the maximum amount of quercetin at the time of high pressure treatment for 10 minutes. content was shown.
상기 결과는 금은화의 고압 처리 시간을 조절함으로써 항비만과 관련있는 클로로겐산, 카페익산, 4,5-디카페오일퀸산, 3,5-디카페오일퀸산, 루틴, 퀘르세틴 및 루테올린의 함량을 유의적으로 증가시켜 현저하게 우수한 비만 억제용 조성물로 사용될 수 있음을 시사한다.The above results showed that the content of chlorogenic acid, caffeic acid, 4,5-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, rutin, quercetin and luteolin, which are related to anti-obesity, was significantly reduced by controlling the high-pressure treatment time of gold and silver coins. It suggests that it can be used as a remarkably excellent composition for suppressing obesity.
1-4. 고압 처리한 금은화의 HPLC를 이용한 유기산 함량 분석1-4. Analysis of organic acid content using HPLC of high-pressure treated gold and silver coins
상기 고압 처리한 금은화의 이화학적 특성을 분석하기 위해 유기산의 함량을 분석하였다.In order to analyze the physicochemical properties of the high-pressure treated gold and silver coins, the content of organic acids was analyzed.
구체적으로, 0.1 g의 실시예 및 대조군 시료에 증류수 5 mL를 가한 후, 1분간 볼텍싱하고 30분간 소니케이션 후 3,500 rpm에서 20분간 원심분리하였다. 상등액은 0.45 um 멤브레인 필터(Millipore, Ireland)로 필터링하여 준비하였다. Aglient 1200 HPLC system (Aglient Technologies, Palo Alto, USA)를 이용하여 하기 표 6의 조건에서 유기산의 함량을 분석하였다(도 2).Specifically, 5 mL of distilled water was added to 0.1 g of Example and Control samples, followed by vortexing for 1 minute, sonication for 30 minutes, and centrifugation at 3,500 rpm for 20 minutes. The supernatant was prepared by filtering with a 0.45 um membrane filter (Millipore, Ireland). The content of organic acids was analyzed under the conditions shown in Table 6 below using the Aglient 1200 HPLC system (Aglient Technologies, Palo Alto, USA) (FIG. 2).
퀸산(quinic acid), 사과산(malic acid), 시킴산(shikimic acid) 및 구연산(Citric acid)을 유기산의 스탠다드 물질로 사용하였다.Quinic acid, malic acid, shikimic acid and citric acid were used as standard materials for organic acids.
도 2를 참조하면, 퀸산, 사과산, 시킴산 및 구연산의 함량은 고압 처리에 의해 영향을 받지 않았으며, 이는 고압 처리시 클로로겐산의 가수분해가 많이 일어나지 않아 유기산의 함량이 증가하지 않았기 때문으로 볼 수 있다.Referring to FIG. 2 , the contents of quinic acid, malic acid, shikimic acid and citric acid were not affected by the high pressure treatment, which could be attributed to the fact that the hydrolysis of chlorogenic acid did not occur much during the high pressure treatment and the organic acid content did not increase. there is.
실험예 2. 고압 처리한 금은화의 항산화 활성 평가Experimental Example 2. Evaluation of antioxidant activity of high-pressure treated gold and silver coins
상기 고압 처리한 금은화의 항산화 활성을 평가하였다.The antioxidant activity of the high-pressure treated gold and silver coins was evaluated.
구체적으로, 실시예 1 내지 5및 대조군(고압 처리 하지 않은 금은화) 시료 0.1 g에 70 % (v/v) 메탄올 10 mL를 가하였다. 이후 1분간 볼텍싱한 후 30분간 소니케이션하고 3,500 rpm에서 20분 간 원심분리하였다. 상등액은 70 % (v/v) 메탄올로 10배 희석하였으며 이후 각각의 항산화 활성 평가에 이용하였다.Specifically, 10 mL of 70% (v/v) methanol was added to 0.1 g of Examples 1 to 5 and the control (gold and silver coin not subjected to high pressure treatment) samples. After vortexing for 1 minute, sonicated for 30 minutes, and centrifuged at 3,500 rpm for 20 minutes. The supernatant was diluted 10-fold with 70% (v/v) methanol and then used to evaluate each antioxidant activity.
2-1. DPPH 라디칼 소거능 측정2-1. Measurement of DPPH radical scavenging ability
고압 처리한 금은화의 DPPH 라디칼 소거능은 Blois 방법(Blois MS 1958)을 변형하여 측정하였다.The DPPH radical scavenging ability of high-pressure-treated gold and silver coins was measured by modifying the Blois method (Blois MS 1958).
구체적으로, 실시예 1 내지 5및 대조군 시료 0.2 mL에 200 mM DPPH를 0.6 mL를 가한 후 15 분간 암실에서 보관하였다. 이후 517 nm에서 흡광도를 측정하였고, 항산화제인 아스코르브산에 대한 ascorbic acid equivalent antioxidant capacity(AEAC)로 비교 및 산출하였다(도 3).Specifically, after adding 0.6 mL of 200 mM DPPH to 0.2 mL of Examples 1 to 5 and the control sample, it was stored in a dark room for 15 minutes. Then, absorbance was measured at 517 nm, and compared and calculated as ascorbic acid equivalent antioxidant capacity (AEAC) for ascorbic acid, an antioxidant ( FIG. 3 ).
도 3을 참조하면, 고압 처리한 실시예 1 내지 5의 경우, 대조군과 비교하여 현저하게 우수한 DPPH 라디칼 소거능을 보였으며, 특히, 실시예 1에서 DPPH 라디칼 소거능이 최대임을 확인하였다.Referring to FIG. 3 , in the case of Examples 1 to 5 treated with high pressure, the DPPH radical scavenging ability was significantly superior to that of the control group, and in particular, it was confirmed that the DPPH radical scavenging ability was the maximum in Example 1.
2-2. ABTS 라디칼 소거능 측정2-2. ABTS radical scavenging activity measurement
고압 처리한 금은화의 ABTS 라디칼 소거능은 Indian Journal of Geo-Marine Sciences Vol. 42(5), September 2013, pp. 556-564 「 Comparison of DPPH and ABTS assays for determining antioxidant potential of water and methanol extracts of Spirulina platensis」의 방법을 변형하여 측정하였다. ABTS radical scavenging activity of gold and silver coins treated with high pressure was published in Indian Journal of Geo-Marine Sciences Vol. 42(5), September 2013, pp. 556-564 The method of "Comparison of DPPH and ABTS assays for determining antioxidant potential of water and methanol extracts of Spirulina platensis " was modified and measured.
구체적으로, ABTS+ 용액을 만들기 위해, 7 mM ABTS 시약과 2.45 mM potassium persulfate를 1:1 (v/v)로 섞은 후 암실에서 12 내지 16 시간 방치하였다. 이후 만들어진 ABTS+ 시약을 메탄올로 희석해 734 nm에서의 흡광도 값을 0.700±0.005로 조정하였다.Specifically, to prepare ABTS + solution, 7 mM ABTS reagent and 2.45 mM potassium persulfate were mixed at a ratio of 1:1 (v/v), and then left in a dark room for 12 to 16 hours. Then, the prepared ABTS + reagent was diluted with methanol to adjust the absorbance value at 734 nm to 0.700±0.005.
실시예 1 내지 5및 대조군 시료 0.1 mL에 ABTS+ 0.9 mL를 가한 후, 암실에서 6 분간 보관하였다. 734 nm에서 흡광도를 측정하였고 항산화제인 트로록스에 대한 Trolox equivalent antioxidant capacity (TEAC)로 비교 및 산출하였다(도 4).After adding ABTS + 0.9 mL to 0.1 mL of Examples 1 to 5 and the control sample, it was stored in a dark room for 6 minutes. Absorbance was measured at 734 nm and compared and calculated as Trolox equivalent antioxidant capacity (TEAC) for the antioxidant Trolox (FIG. 4).
도 4를 참조하면, 실시예 1 내지 5의 경우 대조군과 비교하여 현저하게 우수한 ABTS 라디칼 소거능을 보였으며, 특히, 실시예 1의 ABTS 라디칼 소거능이 최대로 나타났다.Referring to FIG. 4 , Examples 1 to 5 showed remarkably superior ABTS radical scavenging ability compared to the control group, and in particular, Example 1 showed the greatest ABTS radical scavenging ability.
2-3. FRAP(Ferric reducing antioxidant power) 측정2-3. FRAP (Ferric reducing antioxidant power) measurement
실시예 1 내지 5 및 대조군의 FRAP(Ferric reducing antioxidant power) 값은 ANALYTICAL BIOCHEMISTRY 239, 70-76 (1996) 「The Ferric Reducing Ability of Plasma (FRAP) as a Measure of ''Antioxidant Power'': The FRAP Assay」의 방법을 변형하여 측정하였다.Ferric reducing antioxidant power (FRAP) values of Examples 1 to 5 and the control group are ANALYTICAL BIOCHEMISTRY 239, 70-76 (1996) 「The Ferric Reducing Ability of Plasma (FRAP) as a Measure of ''Antioxidant Power'': The FRAP Assay" was modified and measured.
구체적으로, FRAP 시약은 300 mM 소듐 아세테이트버퍼(sodium acetate buffer, pH 3.6)와 40 mM 염산에 녹인 10 mM 2,4,6,-tripyridyl-s-triazine (TPTZ)과 20 mM FeCl3를 10 : 1 : 1 (v/v/v)로 섞은 후 37°C에서 가온하여 제조하였다.Specifically, the FRAP reagent is 10
실시예 1 내지 5 및 대조군 시료 0.15 mL에 상기 제조한 FRAP 시약 2.85 mL를 가한 후, 37°C의 암실에서 15 분간 보관하였다. 593 nm에서 흡광도를 측정하였고 FeSO4·7H2O (0 내지 1 mM)을 스탠다드 물질로 사용하였다(도 5).After adding 2.85 mL of the FRAP reagent prepared above to 0.15 mL of Examples 1 to 5 and the control sample, it was stored in a dark room at 37°C for 15 minutes. Absorbance was measured at 593 nm, and FeSO 4 ·7H 2 O (0 to 1 mM) was used as a standard material (FIG. 5).
도 5를 참조하면, 실시예 1 내지 5의 경우 대조군과 비교하여 FRAP 값이 현저하게 증가하였으며, 특히, 실시예 1의 FRAP 값이 최대로 나타났다.Referring to FIG. 5 , in the case of Examples 1 to 5, the FRAP value was significantly increased compared to the control group, and in particular, the FRAP value of Example 1 was the maximum.
2-4. 환원력 측정2-4. reducing power measurement
실시예 1 내지 5 및 대조군의 환원력은 Sanjukta et al. (2015), Journal of Functional Foods, 14, 650-658 「Enhancement of antioxidant properties of two soybean varieties of Sikkim Himalayan region by proteolytic Bacillus subtilis fermentation」 의 방법을 변형하여 측정하였다.The reducing power of Examples 1 to 5 and the control was determined by Sanjukta et al. (2015), Journal of Functional Foods , 14 , 650-658 "Enhancement of antioxidant properties of two soybean varieties of Sikkim Himalayan region by proteolytic Bacillus subtilis fermentation" was modified and measured.
구체적으로, 실시예 1 내지 5 및 대조군의 시료 0.1 mL에 200 mM 인산 버퍼(pH 6.6) 0.9 mL및 1 % (w/v) 칼륨 시안화제2철(potassium ferric cyanide) 0.9 mL를 가하였다. 이후 10 % (w/v) 트리클로로아세트산(trichloroacetic acid) 0.9 mL를 가하고 3,500 rpm에서 20 분 간 원심분리하였다. 상등액(0.9 mL)를 증류수 0.9 mL와 0.1 % (w/v) FeCl3 0.9 mL와 섞었고, 700 nm에서 흡광도를 측정하였다. 아스코르브산(0 내지 100 ug/mL)를 스탠다드 물질로 사용하였다(도 6).Specifically, 0.9 mL of 200 mM phosphate buffer (pH 6.6) and 0.9 mL of 1% (w/v) potassium ferric cyanide were added to 0.1 mL of the samples of Examples 1 to 5 and the control group. Then, 0.9 mL of 10% (w/v) trichloroacetic acid was added and centrifuged at 3,500 rpm for 20 minutes. The supernatant (0.9 mL) was mixed with 0.9 mL of distilled water and 0.9 mL of 0.1% (w/v) FeCl 3 , and absorbance was measured at 700 nm. Ascorbic acid (0-100 ug/mL) was used as a standard material (FIG. 6).
도 6을 참조하면, 실시예 1 내지 5 의 경우 대조군과 비교하여 우수한 환원력을 보였으며, 특히, 실시예 1의 환원력이 최대로 나타났다.Referring to FIG. 6 , Examples 1 to 5 showed excellent reducing power compared to the control group, and in particular, Example 1 showed the maximum reducing power.
상기와 같은 결과는 본 발명의 고압 처리 방법을 이용하여 금은화를 가공함으로써 금은화의 항산화 활성이 증진됨을 확인한 것이다.The above results confirm that the antioxidant activity of the gold and silver coins is enhanced by processing the gold and silver coins using the high-pressure treatment method of the present invention.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성요소들도 결합된 형태로 실시될 수 있다.The description of the present invention described above is for illustration, and those of ordinary skill in the art to which the present invention pertains can understand that it can be easily modified into other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. For example, each component described as a single type may be implemented in a distributed manner, and likewise components described as distributed may be implemented in a combined form.
본 발명의 범위는 후술하는 청구범위에 의하여 나타내어지며, 청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the following claims, and all changes or modifications derived from the meaning and scope of the claims and their equivalents should be construed as being included in the scope of the present invention.
Claims (11)
상기 고압 처리는 1 분 내지 40 분 동안 300 MPa 내지 500 MPa에서 이루어지는 것인, 금은화의 가공 방법으로서,
상기 고압 처리 전에 0 ℃ 내지 10 ℃에서 방치하는 단계를 추가로 포함하고,
상기 0 ℃ 내지 10 ℃에서 방치하는 단계는 20 시간 내지 30 시간 동안 이루어지는 것인, 금은화의 가공 방법.High pressure treatment on gold and silver coins ( Lonicera japonica Thunb.);
As a method of processing gold and silver coins, the high pressure treatment is performed at 300 MPa to 500 MPa for 1 minute to 40 minutes,
Further comprising the step of leaving at 0 ℃ to 10 ℃ before the high pressure treatment,
The step of leaving at 0 ℃ to 10 ℃ will be made for 20 to 30 hours, the processing method of gold and silver coins.
상기 금은화는 금은화 원재료, 추출물, 분쇄물, 분산액, 분쇄액, 발효물로 이루어진 군에서 선택되는 하나 이상인 것인, 금은화의 가공 방법.The method of claim 1,
The method for processing gold and silver coins, wherein the gold and silver coins are at least one selected from the group consisting of raw materials for gold and silver coins, extracts, pulverized products, dispersions, pulverized solutions, and fermented products.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210048079A KR102364978B1 (en) | 2018-11-14 | 2021-04-13 | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180139820A KR20200056013A (en) | 2018-11-14 | 2018-11-14 | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity |
KR1020210048079A KR102364978B1 (en) | 2018-11-14 | 2021-04-13 | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180139820A Division KR20200056013A (en) | 2018-11-14 | 2018-11-14 | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210044753A KR20210044753A (en) | 2021-04-23 |
KR102364978B1 true KR102364978B1 (en) | 2022-02-18 |
Family
ID=80495014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210048079A KR102364978B1 (en) | 2018-11-14 | 2021-04-13 | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102364978B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230155283A (en) | 2022-05-03 | 2023-11-10 | (주)생기메디온 | Lonicera japonica tea manufacturing method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101074839B1 (en) | 2010-11-25 | 2011-10-19 | 주식회사 녹십자 | Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease |
CN103655669A (en) * | 2013-11-30 | 2014-03-26 | 福建省农业科学院农业生态研究所 | Processing method of dried honeysuckle product |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160011570A (en) * | 2014-07-21 | 2016-02-01 | 동국대학교 경주캠퍼스 산학협력단 | A composition comprising extract of Lonicerae Flos for enhancing the therapy of diabetes mellitus and obesity |
KR101861796B1 (en) | 2017-03-27 | 2018-05-28 | 국민대학교산학협력단 | An antioxidant composition comprising platycodon grandiflorum extract |
-
2021
- 2021-04-13 KR KR1020210048079A patent/KR102364978B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101074839B1 (en) | 2010-11-25 | 2011-10-19 | 주식회사 녹십자 | Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease |
CN103655669A (en) * | 2013-11-30 | 2014-03-26 | 福建省农业科学院农业生态研究所 | Processing method of dried honeysuckle product |
Non-Patent Citations (1)
Title |
---|
HU Wen 외 6명, "Effects of ultrahigh pressure extraction on yield and antioxidant activity of chlorogenic acid and cynaroside extracted from flower buds of Lonicera japonica", Chin J Nat Med, Vol. 13, N* |
Also Published As
Publication number | Publication date |
---|---|
KR20210044753A (en) | 2021-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Trigueros et al. | Antioxidant activity and protein–polyphenol interactions in a pomegranate (Punica granatum L.) yogurt | |
Abbès et al. | Effect of processing conditions on phenolic compounds and antioxidant properties of date syrup | |
Podsędek et al. | Matrix effects on the stability and antioxidant activity of red cabbage anthocyanins under simulated gastrointestinal digestion | |
López‐Romero et al. | Biological activities of Agave by‐products and their possible applications in food and pharmaceuticals | |
Gomes et al. | Differential contribution of grape peel, pulp, and seed to bioaccessibility of micronutrients and major polyphenolic compounds of red and white grapes through simulated human digestion | |
Tadhani et al. | In vitro antioxidant activities of Stevia rebaudiana leaves and callus | |
Orqueda et al. | Chemical and functional characterization of seed, pulp and skin powder from chilto (Solanum betaceum), an Argentine native fruit. Phenolic fractions affect key enzymes involved in metabolic syndrome and oxidative stress | |
Capanoglu et al. | Procyanidins in fruit from Sour cherry (Prunus cerasus) differ strongly in chainlength from those in Laurel cherry (Prunus lauracerasus) and Cornelian cherry (Cornus mas) | |
da Fonseca Machado et al. | Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments | |
Thomas-Valdés et al. | Changes in polyphenol composition and bioactivity of the native Chilean white strawberry (Fragaria chiloensis spp. chiloensis f. chiloensis) after in vitro gastrointestinal digestion | |
KR101682552B1 (en) | Antioxidant composition comprising red ginseng extracts and berrylike mixtures | |
Durak et al. | Coffee with ginger–Interactions of biologically active phytochemicals in the model system | |
Radenkovs et al. | Wild apple (Malus spp.) by-products as a source of phenolic compounds and vitamin C for food applications | |
Yeo et al. | Effect of fermentation on the phytochemical contents and antioxidant properties of plant foods | |
KR102364978B1 (en) | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity | |
Zhou et al. | Phytochemical profile and antioxidant characteristics of bound and free phenolics from Rosa roxburghii Tratt | |
Song et al. | Quality characteristics and antioxidant activity of regional traditional soybean pastes (Deonjang) in Jeonbuk Province | |
KR20200056013A (en) | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity | |
KR102364977B1 (en) | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity | |
Subhash et al. | Current insights into date by-product valorization for sustainable food industries and technology | |
KR20200056012A (en) | Method of processing lonicera japonica thunb to increase anti-oxidant and anti-obesity | |
Sieniawska et al. | Procyanidins in food | |
KR101502219B1 (en) | A antioxidant composition containing enzyme extract or fractions of aloe | |
Marnewick | Antioxidant Properties of Rooibos (Aspalathus linearis)—In Vitro and in Vivo Evidence | |
Jiang et al. | Anthocyanins in food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |